{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:13:00Z","timestamp":1792843980615,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.heliyon.2024.e25531","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T12:32:38Z","timestamp":1706617958000},"page":"e25531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Revolutionizing snakebite care with novel antivenoms: Breakthroughs and barriers"],"prefix":"10.1016","volume":"10","author":[{"given":"Samuel Odo","family":"Uko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Malami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasimu Ghandi","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiu","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bashir","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtala Bello","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha Umar","family":"Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e25531_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10635150802040605","article-title":"The taming of the skew: estimating proper confidence intervals for divergence dates","volume":"57","author":"Burbrink","year":"2008","journal-title":"Syst. Biol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib2","series-title":"Snakes of the World: A Catalogue of Living and Extinct Species","author":"Wallach","year":"2014"},{"key":"10.1016\/j.heliyon.2024.e25531_bib3","first-page":"11","article-title":"The rise of genomics in snake venom research: recent advances and future perspectives","author":"Rao","year":"2022","journal-title":"GigaScience"},{"key":"10.1016\/j.heliyon.2024.e25531_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.842576","article-title":"Plant-derived toxin inhibitors as potential Candidates to complement antivenom treatment in snakebite envenomations","volume":"13","author":"Adriao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tree.2012.10.020","article-title":"Complex cocktails: the evolutionary novelty of venoms","volume":"28","author":"Casewell","year":"2013","journal-title":"Trends Ecol. Evol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib7","article-title":"Snakebite envenoming","volume":"3","author":"Gutierrez","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.heliyon.2024.e25531_bib8","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1371\/journal.pmed.0030150","article-title":"Confronting the neglected problem of snake bite envenoming: the need for a global partnership","volume":"3","author":"Gutierrez","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.heliyon.2024.e25531_bib10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4269\/ajtmh.21-0266","article-title":"The burden of snakebite in rural communities in Kenya: a Household survey","volume":"105","author":"Ooms","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2024.e25531_bib11","series-title":"Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins","first-page":"197","author":"Who","year":"2017"},{"key":"10.1016\/j.heliyon.2024.e25531_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/0049475519865036","article-title":"Comparing community and hospital data of snakebite in North Bihar: a community incidence survey and a parallel hospital-based clinical study","volume":"49","author":"Armstrong","year":"2019","journal-title":"Trop. Doct."},{"key":"10.1016\/j.heliyon.2024.e25531_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/14789450.2014.900447","article-title":"Next-generation snake venomics: protein-locus resolution through venom proteome decomplexation","volume":"11","author":"Calvete","year":"2014","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.heliyon.2024.e25531_bib14","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.3390\/toxins6123388","article-title":"Omics meets biology: application to the design and preclinical assessment of antivenoms","volume":"6","author":"Calvete","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2748962","article-title":"Anti-Metalloprotease P-I single-domain antibodies: tools for next-generation snakebite antivenoms","volume":"2022","author":"Silva","year":"2022","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2024.e25531_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14100694","article-title":"Early adverse reactions to snake antivenom: Poison center data analysis","volume":"14","author":"Sriapha","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and consequences of snake venom variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.heliyon.2024.e25531_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1113\/jphysiol.1887.sp000253","article-title":"Experiments on the preventive Inoculation of rattlesnake venom","volume":"8","author":"Sewall","year":"1887","journal-title":"J. Physiol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/11207250-000000000-00000","article-title":"Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation","volume":"25","author":"Keating","year":"2011","journal-title":"BioDrugs"},{"key":"10.1016\/j.heliyon.2024.e25531_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxicon.2022.06.006","article-title":"Developing a computational pharmacokinetic model of systemic snakebite envenomation and antivenom treatment","volume":"215","author":"Morris","year":"2022","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biologicals.2020.08.005","article-title":"Critical aspects on traditional antivenom production processes and their optimization by factorial analysis","volume":"68","author":"Zurbano","year":"2020","journal-title":"Biologicals"},{"key":"10.1016\/j.heliyon.2024.e25531_bib22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/sj.bjp.0707351","article-title":"The snake venom metalloproteinase BaP1 induces joint hypernociception through TNF-\u03b1 and PGE2-dependent mechanisms","volume":"151","author":"Fernandes","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib23","article-title":"Observation of Bothrops atrox snake envenoming blister formation from five patients: pathophysiological insights","volume":"12","author":"Gimenes","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.annemergmed.2017.04.034","article-title":"The efficacy of crotalidae polyvalent immune Fab (ovine) antivenom versus placebo plus optional rescue therapy on recovery from copperhead snake envenomation: a randomized, double-blind, placebo-controlled, clinical trial","volume":"70","author":"Gerardo","year":"2017","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.heliyon.2024.e25531_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10120534","article-title":"Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims","volume":"10","author":"Kini","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14070443","article-title":"Exploring the utility of recombinant snake venom serine protease toxins as immunogens for generating experimental snakebite antivenoms","volume":"14","author":"Alomran","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114135","article-title":"Snake antivenom: challenges and alternate approaches","volume":"181","author":"Alangode","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajem.2007.06.017","article-title":"The efficacy of low-dose antivenom therapy on morbidity and mortality in snakebite cases","volume":"26","author":"A\u00e7ikalin","year":"2008","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.heliyon.2024.e25531_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0035-9203(98)90802-1","article-title":"Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon","volume":"92","author":"Chippaux","year":"1998","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2024.e25531_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1067\/mem.2001.113372","article-title":"Efficacy, safety, and use of snake antivenoms in the United States","volume":"37","author":"Dart","year":"2001","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.heliyon.2024.e25531_bib31","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.trstmh.2008.04.038","article-title":"Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration","volume":"102","author":"Leon","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2024.e25531_bib32","doi-asserted-by":"crossref","first-page":"e2326","DOI":"10.1371\/journal.pntd.0002326","article-title":"Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation","volume":"7","author":"Stone","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e25531_bib33","first-page":"369","article-title":"Randomized controlled trial on the effective dose of anti-snake venom in cases of snake bite with systematic envenomation","volume":"47","author":"Tariang","year":"1999","journal-title":"JAPI"},{"key":"10.1016\/j.heliyon.2024.e25531_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s13181-010-0051-4","article-title":"A controlled clinical trial of a novel antivenom in patients envenomed by Bungarus multicinctus","volume":"6","author":"Ha","year":"2010","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib35","series-title":"Recombinant Antivenoms","author":"Laustsen","year":"2016"},{"key":"10.1016\/j.heliyon.2024.e25531_bib36","first-page":"12","article-title":"Bibliometric analysis of literature in snake venom-related research worldwide (1933-2022)","author":"Sofyantoro","year":"2022","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.heliyon.2024.e25531_bib37","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/dta.3108","article-title":"The application of laboratory-based analytical tools and techniques for the quality assessment and improvement of commercial antivenoms used in the treatment of snakebite envenomation","volume":"13","author":"Patra","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.heliyon.2024.e25531_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxicon.2016.08.011","article-title":"Efficacy of intravenous hydrocortisone administered 2-4 h prior to antivenom as prophylaxis against adverse drug reactions to snake antivenom in Sri Lanka: an open labelled randomized controlled trial","volume":"120","author":"Kularatne","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280836","article-title":"Risks of snakebite and challenges to seeking and providing treatment for agro-pastoral communities in Tanzania","volume":"18","author":"Francis","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e25531_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.toxicon.2018.05.009","article-title":"The snakebite problem and antivenom crisis from a health-economic perspective","volume":"150","author":"Habib","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008374","article-title":"Challenges and prospects of snake antivenom supply in sub-Saharan Africa","volume":"14","author":"Habib","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e25531_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.11160\/bah.233","article-title":"Influence of size, sex and age on venom yield of Bothrops leucurus (Serpentes, Viperidae) under captivity conditions","volume":"37","author":"Braga","year":"2022","journal-title":"Basic Appl. Herpetol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124478","article-title":"Recent advancements in snake antivenom production","volume":"240","author":"Rathore","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib44","article-title":"Experimental antivenoms from chickens and rabbits and their comparison with commercially available equine antivenom against the venoms of Daboia russelii and Echis carinatus snakes","volume":"1\u201312","author":"Choraria","year":"2020","journal-title":"Toxin Rev."},{"key":"10.1016\/j.heliyon.2024.e25531_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.54817\/IC.v63n1a05","article-title":"A new approach of immunotherapy against crotalus snakes envenoming: ostrich (Struthio camelus) egg yolk antibodies (IgY-technology)","volume":"63","author":"Bello","year":"2022","journal-title":"Invest. Clin."},{"key":"10.1016\/j.heliyon.2024.e25531_bib46","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BCJ20160577","article-title":"Venomics: integrative venom proteomics and beyond","volume":"474","author":"Calvete","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.heliyon.2024.e25531_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14090606","article-title":"Antibodies as snakebite antivenoms: past and future","volume":"14","author":"Dias da Silva","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.toxicon.2016.10.018","article-title":"rBaltMIP, a recombinant alpha-type myotoxin inhibitor from Bothrops alternatus (Rhinocerophis alternatus) snake, as a potential candidate to complement the antivenom therapy","volume":"124","author":"Santos-Filho","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005361","article-title":"Recombinant snakebite antivenoms: a cost-competitive solution to a neglected tropical disease?","volume":"11","author":"Laustsen","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e25531_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13080556","article-title":"Development of a broad-spectrum antiserum against cobra venoms using recombinant three-finger toxins","volume":"13","author":"Liu","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00703","article-title":"Cost of manufacturing for recombinant snakebite antivenoms","volume":"8","author":"Jenkins","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/538041e","article-title":"Snakebites: costing recombinant antivenoms","volume":"538","author":"Laustsen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e25531_bib53","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/biot.201300480","article-title":"Economics of recombinant antibody production processes at various scales: industry-standard compared to continuous precipitation","volume":"9","author":"Hammerschmidt","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.heliyon.2024.e25531_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2085536","article-title":"In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom","volume":"14","author":"Ledsgaard","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.heliyon.2024.e25531_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10110452","article-title":"Innovative immunization strategies for antivenom development","volume":"10","author":"Bermudez-Mendez","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib56","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.vaccine.2003.09.046","article-title":"Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming","volume":"22","author":"Harrison","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2024.e25531_bib57","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2249.2000.01287.x","article-title":"Antibody from mice immunized with DNA encoding the carboxyl-disintegrin and cysteine-rich domain (JD9) of the haemorrhagic metalloprotease, Jararhagin, inhibits the main lethal component of viper venom","volume":"121","author":"Harrison","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cbpa.2008.07.024","article-title":"Mass spectrometry for proteomics","volume":"12","author":"Han","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib59","series-title":"Snake Venom Proteopeptidomics: what Lies behind the Curtain","first-page":"333","author":"Richard","year":"2016"},{"key":"10.1016\/j.heliyon.2024.e25531_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0041-0101(85)90144-8","article-title":"Liposomal immunisation against snake venoms","volume":"23","author":"New","year":"1985","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib61","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3389\/fimmu.2019.02422","article-title":"A combined strategy to improve the development of a coral antivenom against Micrurus spp","volume":"10","author":"de Castro","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib62","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.vaccine.2008.11.103","article-title":"Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom","volume":"27","author":"Waghmare","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2024.e25531_bib63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxicon.2021.04.005","article-title":"Neutralization of crotamine by polyclonal antibodies generated against two whole rattlesnake venoms and a novel recombinant fusion protein","volume":"197","author":"Ponce-Lopez","year":"2021","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib64","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/pbi.12823","article-title":"A synthetic biology approach for consistent production of plant-made recombinant polyclonal antibodies against snake venom toxins","volume":"16","author":"Parreno","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.heliyon.2024.e25531_bib65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.toxicon.2019.02.011","article-title":"Expression of an scFv antibody fragment in Nicotiana benthamiana and in vitro assessment of its neutralizing potential against the snake venom metalloproteinase BaP1 from Bothrops asper","volume":"160","author":"Gomes","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib66","article-title":"Recent advances in next generation snakebite antivenoms","volume":"3","author":"Knudsen","year":"2018","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e25531_bib67","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijbiomac.2021.06.043","article-title":"Engineering of single-domain antibodies for next-generation snakebite antivenoms","volume":"185","author":"Fernandes","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.toxicon.2016.12.010","article-title":"Pitfalls to avoid when using phage display for snake toxins","volume":"126","author":"Laustsen","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib69","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4161\/hv.21703","article-title":"Phage display\u2014a powerful technique for immunotherapy","volume":"8","author":"Bazan","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.heliyon.2024.e25531_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10060236","article-title":"Basics of antibody phage display technology","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib71","volume":"vol. 8","author":"Richard","year":"2013"},{"key":"10.1016\/j.heliyon.2024.e25531_bib72","series-title":"Phage Display: Factors Affecting Panning Efficiency. Phage Display of Peptides and Proteins: A Laboratory Manual","first-page":"261","author":"McCafferty","year":"1996"},{"key":"10.1016\/j.heliyon.2024.e25531_bib73","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/7959","article-title":"Selection of high-affinity phage antibodies from phage display libraries","volume":"17","author":"Bruin","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2144\/000114256","article-title":"Introduction of plasmid encoding for rare tRNAs reduces amplification bias in phage display biopanning","volume":"58","author":"Umlauf","year":"2015","journal-title":"Biotechniques"},{"key":"10.1016\/j.heliyon.2024.e25531_bib75","doi-asserted-by":"crossref","first-page":"R254","DOI":"10.1186\/gb-2007-8-11-r254","article-title":"Application of phage display to high throughput antibody generation and characterization","volume":"8","author":"Schofield","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jim.2006.10.005","article-title":"A fast and efficient procedure to produce scFvs specific for large macromolecular complexes","volume":"318","author":"Wu","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.heliyon.2024.e25531_bib77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.toxicon.2014.11.001","article-title":"Phage display as a novel promising antivenom therapy: a review","volume":"93","author":"Roncolato","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib78","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jim.2006.03.005","article-title":"A fast mutagenesis procedure to recover soluble and functional scFvs containing amber stop codons from synthetic and semisynthetic antibody libraries","volume":"312","author":"Barderas","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.heliyon.2024.e25531_bib79","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.bbagen.2018.08.019","article-title":"Nanobodies as novel therapeutic agents in envenomation","volume":"1862","author":"Alirahimi","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.heliyon.2024.e25531_bib80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbt.2017.05.005","article-title":"Guiding recombinant antivenom development by omics technologies","volume":"45","author":"Laustsen","year":"2018","journal-title":"N Biotechnol"},{"key":"10.1016\/j.heliyon.2024.e25531_bib81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib82","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","article-title":"The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions","volume":"2","author":"Harding","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.heliyon.2024.e25531_bib83","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/348552a0","article-title":"Phage antibodies: filamentous phage displaying antibody variable domains","volume":"348","author":"McCafferty","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e25531_bib84","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-023-36393-4","article-title":"Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain alpha-neurotoxins from snakes","volume":"14","author":"Ledsgaard","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e25531_bib85","series-title":"Discovery of a Broadly-Neutralizing Human Antibody that Can Rescue","author":"Ledsgaard","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e25531_bib86","series-title":"In Vitro Discovery and Optimization of a Human Monoclonal Antibody that Neutralizes Neurotoxicity and Lethality of Cobra Snake Venom","author":"Ledsgaard","year":"2021"},{"key":"10.1016\/j.heliyon.2024.e25531_bib87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.actatropica.2017.09.001","article-title":"Discovery of human scFvs that cross-neutralize the toxic effects of B. jararacussu and C. d. terri\ufb01cus venoms","volume":"177","author":"Silva","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.heliyon.2024.e25531_bib88","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-018-06086-4","article-title":"In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e25531_bib89","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-2019-0099","article-title":"Recombinant antibodies against Iranian cobra venom as a new emerging therapy by phage display technology","volume":"26","author":"Nazari","year":"2020","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e25531_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11060363","article-title":"The urgent need to develop novel strategies for the diagnosis and treatment of snakebites","volume":"11","author":"Williams","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib91","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.toxicon.2008.05.023","article-title":"Immunization with cDNA of a novel P-III type metalloproteinase from the rattlesnake Crotalus durissus durissus elicits antibodies which neutralize 69% of the hemorrhage induced by the whole venom","volume":"52","author":"Azofeifa-Cordero","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib92","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/toxins14060418","article-title":"Computer-aided analysis of west sub-Saharan Africa snakes venom towards the design of epitopebased poly-specific antivenoms","volume":"14","author":"Ros-Lucas","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib93","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijbiomac.2020.05.171","article-title":"Immunoprotection against lethal effects of Crotalus durissus snake venom elicited by synthetic epitopes trapped in liposomes","volume":"161","author":"Melo","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib94","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biologicals.2011.02.005","article-title":"Antivenoms for the treatment of snakebite envenomings: the road ahead","volume":"39","author":"Gutierrez","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.heliyon.2024.e25531_bib95","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/toxins14040265","article-title":"Anti-neurotoxins from Micrurus mipartitus in the development of coral Snake antivenoms","volume":"14","author":"Cardona-Ruda","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004484","article-title":"A heterologous multiepitope DNA prime\/recombinant protein boost immunisation strategy for the development of an antiserum against Micrurus corallinus (coral snake) venom","volume":"10","author":"Ramos","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e25531_bib97","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/emi.2016.27","article-title":"DNA immunization as a technology platform for monoclonal antibody induction","volume":"5","author":"Liu","year":"2016","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.heliyon.2024.e25531_bib98","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1038\/s41467-020-19981-6","article-title":"A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite","volume":"11","author":"Albulescu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e25531_bib99","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8314","article-title":"Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite","volume":"12","author":"Albulescu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e25531_bib100","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4320175","article-title":"Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite","volume":"2018","author":"Bulfone","year":"2018","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.heliyon.2024.e25531_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13070451","article-title":"The search for natural and synthetic inhibitors that would complement antivenoms as therapeutics for snakebite envenoming","volume":"13","author":"Gutierrez","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib102","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1021\/jm900648x","article-title":"Hydroxamates: relationships between structure and plasma stability","volume":"52","author":"Flipo","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e25531_bib103","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/toxins8090248","article-title":"Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation","volume":"8","author":"Lewin","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib104","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2017.04.001","article-title":"Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom","volume":"132","author":"Arias","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s42003-018-0039-1","article-title":"The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms","volume":"1","author":"Ainsworth","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib106","first-page":"313","article-title":"Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA","volume":"63","author":"Escalante","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2024.e25531_bib107","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.toxicon.2019.06.005","article-title":"Engineering and design considerations for next-generation snakebite antivenoms","volume":"167","author":"Knudsen","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.toxicon.2014.05.017","article-title":"A neutralizing recombinant single chain antibody, scFv, against BaP1, A P-I hemorrhagic metalloproteinase from Bothrops asper snake venom","volume":"87","author":"Castro","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib109","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fimmu.2020.00655","article-title":"Development of nanobodies against hemorrhagic and myotoxic components of Bothrops atrox snake venom","volume":"11","author":"Bailon","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib110","first-page":"1536","article-title":"Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts","volume":"40","author":"Pavlinkova","year":"1999","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.heliyon.2024.e25531_bib111","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fcimb.2013.00072","article-title":"Engineering production of functional scFv antibody in E. Coli by co-expressing the molecule chaperone Skp","volume":"3","author":"Wang","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib112","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/acs.bioconjchem.2c00220","article-title":"Generation of multivalent nanobody-based proteins with improved neutralization of long alpha-neurotoxins from elapid snakes","volume":"33","author":"Wade","year":"2022","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.heliyon.2024.e25531_bib113","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3389\/fimmu.2019.01598","article-title":"History of envenoming therapy and current perspectives","volume":"10","author":"Pucca","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e25531_bib114","series-title":"Snakebite Antivenoms: Global Challenges and Progress toward Recombinant Antibody Therapeutics","author":"Antibody Society","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e25531_bib115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The safety and side effects of monoclonal antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e25531_bib116","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e25531_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.05.001","article-title":"Clinical studies of the effectiveness and safety of antivenoms","volume":"150","author":"Williams","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.heliyon.2024.e25531_bib118","volume":"vol. 8","author":"Almagro","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e25531_bib119","volume":"vol. 24","author":"Gomez-Betancur","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e25531_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10080309","article-title":"Integrating engineering, manufacturing, and regulatory considerations in the development of novel antivenoms","volume":"10","author":"Laustsen","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e25531_bib121","first-page":"21","article-title":"Diagnostic and therapeutic value of aptamers in envenomation cases","author":"Ascoet","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e25531_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010915","article-title":"Potential economic and clinical implications of improving access to snake antivenom in five ASEAN countries: a cost-effectiveness analysis","volume":"16","author":"Patikorn","year":"2022","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e25531_bib123","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/15563650.2018.1491982","article-title":"Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients","volume":"57","author":"Anderson","year":"2019","journal-title":"Clin. Toxicol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024015627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024015627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:31:18Z","timestamp":1775457078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024015627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":122,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2405844024015627"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25531","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revolutionizing snakebite care with novel antivenoms: Breakthroughs and barriers","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e25531"}}